Chief Scientific Officer · Olema Pharmaceuticals, Inc. (OLMA)

Peter Kushner

A named executive officer of Olema Pharmaceuticals in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,024,715

Salary $293,452Stock awards $344,046

FY2019: $200,000

3rd of 4 named executive officers at Olema Pharmaceuticals by FY2020 total.

4 named officers on file for Olema Pharmaceuticals, FY2020

Peter Kushner’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • OLMA’s disclosed peer group of 28 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Olema Pharmaceuticals’s whole pay program stands against its peers

  • Olema Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OLMA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Peter Kushner’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Peter Kushner compensation by year

Olema Pharmaceuticals Summary Compensation Table · all 2 fiscal years held
In US dollars, as Olema Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$200,000$293,452
Bonus$0$0
Stock awards—$344,046
Option awards—$2,250,717
Non-equity incentive—$136,500
Pension and deferred compensation$0$0
All other$0$0
Total$200,000$3,024,715

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Olema Pharmaceuticals, Inc. DEF 14A filed April 27, 2021, accession 0001558370-21-004911, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Olema Pharmaceuticals, Inc. filed document, accession 0001558370-21-004911. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$200K
$3.0M
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awards

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU125,538$6,035,867—
Option179,340—$19.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Olema Pharmaceuticals, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Olema Pharmaceuticals’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Sean BohenPresident and Chief Executive Officer$10,598,498
Cyrus HarmonChief Technology Officer and former Chief Executive Officer (4)$3,976,890
Peter Kushner · this pageChief Scientific Officer$3,024,715
John MoriartyExecutive Vice President, Chief Legal Officer$3,016,961

The full Olema Pharmaceuticals compensation record

free company brief

This page is one person within Olema Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Olema Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Olema Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Peter Kushner's compensation dossier · One-time report. No refunds.